SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-16-000401
Filing Date
2016-06-10
Accepted
2016-06-10 09:56:55
Documents
2
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1090
2 enzndelistreason.txt EX-99.25 816
  Complete submission text file 0001354457-16-000401.txt   3767
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 000-12957
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9600 BLACKWELL RD ROCKVILLE MD 20850
Business Address 9600 BLACKWELL RD ROCKVILLE MD 20850 301-978-4144
NASDAQ Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

IRS No.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE